PRMT5 and acute myeloid leukemia: Indeed, PRMT5 depletion or inhibition downregulates roughly 50% of genes that exhibit 2-fold change (~1,300 genes) in AML, of which 53% (335 genes) restored expression upon inhibition of the H3K27 methyltransferase, EZH2.